🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The clinical trial will assess the safety, tolerability, and immunogenicity...
Status
Completed
Location
Clinical Research of Puerto Rico
Start Date
2016-08
Trial ID
NCT02887482
Therapeutic HIV vaccines are designed to control HIV infection by boosting ...
Status
Completed
Location
UCLA CARE Center CRS
Start Date
2011-03
Trial ID
NCT01266616
Treatments Being Tested
The central premise of our program is that durable control of HIV in the ab...
Status
Completed
Location
University of California, Los Angeles
Start Date
2018-08-01
Trial ID
NCT03606213
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and immun...
Status
Completed
Location
Kenya AIDS Vaccine Initiative, Kangemi
Start Date
2011-12
Trial ID
NCT01496989
Treatments Being Tested
The purpose of this study is to evaluate the safety of and immune response ...
Status
Completed
Location
Rockville Vaccine Assessment Clinic (RVAC)
Start Date
2010-02
Trial ID
NCT01260727
Treatments Being Tested
This is a phase I/IIa trial to evaluate the safety, tolerability and immuno...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2020-07-15
Trial ID
NCT04447781
Treatments Being Tested
This is a randomized, blinded, placebo-controlled trial to evaluate the saf...
Status
Completed
Location
Noguchi Memorial Institute for Medical Research, University of Ghana
Start Date
2021-01-27
Trial ID
NCT04093076
Treatments Being Tested
This study evaluated the safety, immunogenicity, and preliminary assessment...
Status
Completed
Location
Alabama CRS
Start Date
2019-03-26
Trial ID
NCT03560258
The purpose of this study is to access the efficacy and safety of GX-188E a...
Status
Unknown
Location
East Tallinn Central Hospital
Start Date
2015-08
Trial ID
NCT02596243
CUT\*HIVTHER 001 is a randomised placebo-controlled Phase I/II study aimed ...
Status
Completed
Location
Imperial College London
Start Date
2015-07
Trial ID
NCT02457689
Treatments Being Tested